Lead sponsor
AB Science
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
1
Ongoing
1,355
Total enrollment
15
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Phase 3
2
Trials by status
Not yet recruiting
1
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 2Completed34